Prednisone and Libtayo drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Prednisone (prednisone) and Libtayo (cemiplimab-rwlc). Common drug interactions include paraesthesia among females and squamous cell carcinoma of skin among males.
The phase IV clinical study analyzes what interactions people have when they take Prednisone and Libtayo. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Prednisone?
Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.
What is Libtayo?
Libtayo has active ingredients of cemiplimab-rwlc. eHealthMe is studying from 1,161 Libtayo users. Check the latest studies of Libtayo.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
32 people who take Prednisone and Libtayo together, and have interactions are studied.
What are the common drug interactions of Prednisone and Libtayo, by gender? *:
female:
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Hepatotoxicity (chemical-driven liver damage)
- Nausea (feeling of having an urge to vomit)
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
- Vomiting
- Ascites (accumulation of fluid in the abdominal cavity)
- Blood pressure increased
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Disease progression
- Drug ineffective
male:
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
- Arthralgia (joint pain)
- Performance status decreased
- Pneumonia
- Rash
- Skin mass
- Adverse drug reaction
- C-reactive protein increased
- Chronic kidney disease
- Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
What are the common drug interactions of Prednisone and Libtayo, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Nausea (feeling of having an urge to vomit)
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
- Vomiting
- Ascites (accumulation of fluid in the abdominal cavity)
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Disease progression
- Nodular regenerative hyperplasia (regeneration of a skin condition characterized by crops of small, tender, erythematous nodules on the legs)
- Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
- Venoocclusive liver disease (small veins in the liver are obstructed)
60+:
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
- Hepatotoxicity (chemical-driven liver damage)
- Pemphigoid (tense blisters on the skin)
- Performance status decreased
- Pneumonia
- Rash
- Skin mass
- Blood pressure increased
- Drug ineffective
- Interstitial lung disease
What are the existing conditions these people have? *
- Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 16 people, 50.00%
- Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 11 people, 34.38%
- Pain: 5 people, 15.62%
- Uveitis (inflammation of the uvea): 3 people, 9.38%
- Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 9.38%
- Eye Inflammation: 3 people, 9.38%
- Skin Cancer: 2 people, 6.25%
- Rashes (redness): 2 people, 6.25%
- Nephropathy (damage to or disease of a kidney): 2 people, 6.25%
- Immunodeficiency Disorders: 2 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Prednisone and Libtayo?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Prednisone (636,827 reports)
- Libtayo (1,161 reports)
Browse all drug interactions of Prednisone and Libtayo:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Prednisone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Libtayo:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Prednisone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Libtayo and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on prednisone and cemiplimab-rwlc (the active ingredients of Prednisone and Libtayo, respectively), and Prednisone and Libtayo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.